John brings a remarkable breadth of experience in antibody design and development in multiple disease areas.” said Mark DePristo, Ph.D., Chief Executive Officer and Co-founder of BigHat Biosciences. “We couldn't be more excited to work with John in this critical role to expand and advance our pipeline of therapeutic programs to have an impact for patients.

https://www.bighatbio.com/news/bighat-appoints-john-corbin-phd-as-chief-development-officer